Viewing Study NCT05630820

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2026-01-16 @ 5:57 AM
Study NCT ID: NCT05630820
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-12
First Post: 2022-11-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Hepatitis B View
None Hepatitis B, Chronic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatitis View
None Chronic Hepatitis View
None Chronic Hepatitis B View
None Hepatitis B Virus View
None hepatitis B virus e-antigen View
None Bepirovirsen View
None Nucleos(t)ide analog View
None Antisense Oligonucleotide View
None 202009 View
None 219288 View
None Nucleos(t)ide analogue View